Creon (AbbVie Inc.)
Welcome to the PulseAid listing for the Creon drug offered from AbbVie Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AbbVie Inc. |
| NON-PROPRIETARY NAME: | Pancrelipase |
| SUBSTANCE NAME: | PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-04-30 |
| END MARKETING DATE: | 0000-00-00 |
Creon HUMAN PRESCRIPTION DRUG Details:
| Item Description | Creon from AbbVie Inc. |
| LABELER NAME: | AbbVie Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15000; 3000; 9500([USP’U]/1; [USP’U]/1; [USP’U]/1) |
| START MARKETING DATE: | 2009-04-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0032-1203_c1fc1c81-d34a-7baf-ba5c-48425e015fe1 |
| PRODUCT NDC: | 0032-1203 |
| APPLICATION NUMBER: | NDA020725 |
Other PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE Pharmaceutical Manufacturers / Labelers:
